CARVYKTI Significantly Improved Minimal Residual Disease Negati
LEGN Stock | USD 37.90 3.73 8.96% |
About 62% of Legend Biotech's investor base is looking to short. The analysis of the overall investor sentiment regarding Legend Biotech Corp suggests that many traders are alarmed. Legend Biotech's investing sentiment overview a quick insight into current market opportunities from investing in Legend Biotech Corp. Many technical investors use Legend Biotech Corp stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Legend |
89 percent of evaluable patients achieved minimal residual disease negativity with CARVYKTI after three-year follow-up in CARTITUDE-4 study the majorit
Read at gurufocus.com
Legend Biotech Corp Current Investor Sentiment
Panic Vs Confidence
38
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Legend Biotech's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Legend Biotech Corp.
News SentimentNeutral | Hype SentimentBearish | Insider SentimentWaiting |
Legend Biotech Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Legend Biotech can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Legend Biotech Corp Historical Investor Sentiment
Investor biases related to Legend Biotech's public news can be used to forecast risks associated with an investment in Legend. The trend in average sentiment can be used to explain how an investor holding Legend can time the market purely based on public headlines and social activities around Legend Biotech Corp. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Legend Biotech's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Legend Biotech and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Legend Biotech news discussions. The higher the estimate score, the more favorable the investor's outlook on Legend Biotech.
Legend Biotech Fundamental Analysis
We analyze Legend Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Legend Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Legend Biotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Debt
Total Debt Comparative Analysis
Legend Biotech is currently under evaluation in total debt category among its peers. Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Legend Biotech Corp Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Legend Biotech stock to make a market-neutral strategy. Peer analysis of Legend Biotech could also be used in its relative valuation, which is a method of valuing Legend Biotech by comparing valuation metrics with similar companies.
Peers
Legend Biotech Related Equities
ACLX | Arcellx | 8.57 | ||||
TERN | Terns Pharmaceuticals | 5.17 | ||||
BPMC | Blueprint Medicines | 0.87 | ||||
TVTX | Travere Therapeutics | 0.11 | ||||
ETNB | 89bio | 0.37 | ||||
ALNY | Alnylam Pharmaceuticals | 0.78 | ||||
APLS | Apellis Pharmaceuticals | 1.09 | ||||
ZLAB | Zai Lab | 1.12 | ||||
AKRO | Akero Therapeutics | 1.54 | ||||
PCVX | Vaxcyte | 1.77 | ||||
MDGL | Madrigal Pharmaceuticals | 1.78 | ||||
DAWN | Day One | 1.86 | ||||
ASND | Ascendis Pharma | 2.08 | ||||
PLRX | Pliant Therapeutics | 2.22 | ||||
STOK | Stoke Therapeutics | 3.63 | ||||
AMLX | Amylyx Pharmaceuticals | 7.58 |
Check out Legend Biotech Hype Analysis, Legend Biotech Correlation and Legend Biotech Performance. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Legend Biotech. If investors know Legend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Legend Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.92) | Revenue Per Share 2.851 | Quarterly Revenue Growth 0.669 | Return On Assets (0.12) | Return On Equity (0.28) |
The market value of Legend Biotech Corp is measured differently than its book value, which is the value of Legend that is recorded on the company's balance sheet. Investors also form their own opinion of Legend Biotech's value that differs from its market value or its book value, called intrinsic value, which is Legend Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Legend Biotech's market value can be influenced by many factors that don't directly affect Legend Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Legend Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Legend Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Legend Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.